Gene Synthesis Market Growth, Trends and Report Highlights
According to a new report Global Gene Synthesis Market, published by KBV research, The Global Gene Synthesis Market size is expected to reach $5.2 billion by 2027, rising at a market growth of 17.9% CAGR during the forecast period.
The PCR-based Enzyme Synthesis market is expected to witness highest CAGR of 18.3% during (2021 - 2027). Traditional PCR-based gene synthesis entails two steps: first, all overlapping oligonucleotides are self-primed, and then the full-length gene product is amplified using a second set of primers. This method is one of the most accurate conventional method of gene replicating.
The Viral DNA Synthesis market shows highest growth rate in the market of 18.1% during (2021 - 2027). The growth of the segment is attributed to the increasing number of researches and development in the field of virus. The viral DNA synthesis is a procedure following which, biological viruses form within the period of diffusion of the infection in the targeted cells. The virus is required to reach the cell before the completion of the virus replication procedure.
The Vaccine Development market would showcase promising growth rate of 18.2% during (2021 - 2027). Antigenic components are encoded as DNA plasmids for direct in vivo synthesis to elicit adaptive immunity in DNA vaccines. These DNA vaccines are considered a third-generation vaccination technique. DNA vaccination has a high safety profile as compared to other platforms because DNA plasmids do not multiply or trigger vector-directed immune responses in hosts.
The Biotechnology & Pharmaceutical Companies market showcase significant market growth of 18% during (2021 - 2027).
The development of this segment is attributed to the rising number of partnerships and collaboration strategies among various key players of the market across the world. Also, the increase in the government efforts in offering financial assistance in the fields of academics as well as to establish new government research institutes and developing the existing ones is a major driving factor for the growth of the market.
The North America market is generating highest revenue in the Global Gene Synthesis Market by Region 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2,099.9 million by 2027. The Europe market is expected to witness a CAGR of 17.4% during (2021 - 2027). Additionally, The Asia Pacific market is expected to witness a CAGR of 18% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/gene-synthesis-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
Global Gene Synthesis Market Segmentation
• Solid-phase Synthesis
• Chip-based Synthesis and
• PCR-based Enzyme Synthesis
By Service Type
• Antibody DNA Synthesis
• Viral DNA Synthesis and
• Gene & Cell Therapy Development
• Vaccine Development
• Disease Diagnosis and
By End User
• Academic & Government Research Institutes
• Biotechnology & Pharmaceutical Companies and
• Contract Research Organizations
• Rest of North America
• Rest of Europe
• South Korea
• Rest of Asia Pacific
• Saudi Arabia
• South Africa
• Rest of LAMEA
• Genscript Biotech Corporation
• Thermo Fisher Scientific, Inc.
• Brooks Automation, Inc.
• Boster Biological Technology
• Twist Bioscience Corporation
• Danaher Corporation
• Biomatik Corporation
• ProMab Biotechnologies, Inc.
• OriGene Technologies, Inc.